Isomer Capital
Other
Active
London, United States
28
13M
26
4.00
5
0.07
5
- Stages of investment
- Areas of investment
Summary
Isomer Capital is the famous VC, which was founded in 2015. The company was established in Europe in United Kingdom. The main department of described VC is located in the London.
The overall number of key employees were 4.
The fund has exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most successful fund investment fields, there are SaaS, Developer Tools. Among the various public portfolio startups of the fund, we may underline Darktrace, Babylon Health, Job Today
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Isomer Capital, startups are often financed by Entrepreneur First, Speedinvest, Seedcamp. The meaningful sponsors for the fund in investment in the same round are Entrepreneur First, Connect Ventures, Hoxton Ventures. In the next rounds fund is usually obtained by White Star Capital, Hoxton Ventures, Entrepreneur First.
Opposing the other organizations, this Isomer Capital works on 21 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 deals per year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The important activity for fund was in 2016. Speaking about the real fund results, this VC is 8 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 28
- Lead investments
- 5
- Exits
- 5
- Rounds per year
- 4.00
- Follow on index
- 0.07
- Investments by industry
- Software (10)
- Machine Learning (6)
- Artificial Intelligence (6)
- SaaS (5)
- Apps (5) Show 67 more
- Investments by region
-
- Austria (3)
- Belgium (3)
- United Kingdom (14)
- United States (3)
- Luxembourg (1) Show 4 more
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 142M
- Group Appearance index
- 1.00
- Avg. company exit year
- 7
- Avg. multiplicator
- 0.93
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Automata | 22 Feb 2022 | Information Technology, Robotics, Manufacturing, Professional Services, Industrial Automation | Early Stage Venture | 50M | England, London, United Kingdom |
Sibel Health | 04 Aug 2022 | Artificial Intelligence, Health Care, Medical Device, Medical | Early Stage Venture | 33M | United States, Illinois, Niles |
Tractable | 12 Jan 2017 | Software, Artificial Intelligence, Machine Learning, Insurance | Early Stage Venture | 8M | England, London, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.